Prior Art Search and Determination of Novelty, Inventive Step, Etc
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Can I Challenge My Competitor's Patent?
Check out Derek Fahey's new firm's website! CLICK HERE Can I Challenge My Competitor’s Patent? Yes, you can challenge a patent or patent publication. Before challenging a patent or patent publication, an analysis should be conducted by a registered patent attorney to determine if challenging a patent or patent publication is necessary, and to evaluate the legal grounds for challenging the patent or patent publication. As a registered patent attorney, I evaluate patents and patent applications to determine the risk of developing competing goods. Below are three important questions that must be answered by a registered patent attorney to evaluate the risk of competing against a patented good. 1. Does a particular good infringe on a patent? Typically, a registered patent attorney will conduct a “freedom to operate” opinion to determine if a business owner can commercialize a particular good without infringing on another’s patent. First, a patent attorney will determine if the patent is enforceable. Next, a patent attorney will perform an infringement analysis to determine if a particular good infringes on any of a patent’s claims. To perform an infringement analysis of a patent and a possibly infringing product, first, the patent’s scope must be analyzed. Second, the patent’s claim terms must be interrupted using the specification, prosecution history and extrinsic evidence to understand and construe the meaning of the claim terms. After the claim terms have been construed, then the elements of a particular good must be analyzed to determine if the particular good practices each and every claim element taught by a patent’s claim. -
Chapter 2 Novelty and Inventive Step (Patent Act Article 29(1) and (2))
Note: When any ambiguity of interpretation is found in this provisional translation, the Japanese text shall prevail. Part III Chapter 2 Section 1 Novelty Chapter 2 Novelty and Inventive Step (Patent Act Article 29(1) and (2)) Section 1 Novelty 1. Overview Patent Act Article 29(1) provides as the unpatentable cases (i) inventions that were publicly known, (ii) inventions that were publicly worked (iii) inventions that were described in a distributed publication or made available to the public through electric telecommunication lines in Japan or a foreign country prior to the filing of the patent application. The same paragraph provides that a patent shall not be granted for these publicly known (Note) inventions (inventions lacking novelty, hereinafter referred to as "prior art” in this chapter.). The patent system is provided to grant an exclusive right to the patentee in exchange for disclosure of the invention. Therefore, the invention which deserves the patent should be novel. This paragraph is provided to achieve such a purpose. This Section describes the determination of novelty for an invention of the patent applications to be examined (hereinafter referred to as "the present application" in this Section.) (Notes) The term "publicly known" generally falls under Article 29(1)(i), or under the 29(1)(i) to (iii), hereinafter the latter is applied. 2. Determination of Novelty Inventions subject to determination of novelty are claimed inventions. The examiner determines whether the claimed invention has novelty by comparing the claimed inventions and the prior art cited for determining novelty and an inventive step (the cited prior art) to identify the differences between them. -
The European Patent Convention, 3 Md
Maryland Journal of International Law Volume 3 | Issue 2 Article 10 The urE opean Patent Convention Follow this and additional works at: http://digitalcommons.law.umaryland.edu/mjil Part of the International Law Commons, and the International Trade Commons Recommended Citation The European Patent Convention, 3 Md. J. Int'l L. 408 (1978). Available at: http://digitalcommons.law.umaryland.edu/mjil/vol3/iss2/10 This Notes & Comments is brought to you for free and open access by DigitalCommons@UM Carey Law. It has been accepted for inclusion in Maryland Journal of International Law by an authorized administrator of DigitalCommons@UM Carey Law. For more information, please contact [email protected]. THE EUROPEAN PATENT CONVENTION The European Patent Convention' (EPC) is an attempt to simplify European patent law. The Convention provides a procedure for securing a single, European patent,2 which has the effect of a national patent in the signatory nations designated in the application. Through this alternative to national procedures, widespread patent coverage should be easier to obtain. Require- patent, however, are rigorous and its ments for a European 3 attraction is primarily the consolidation of the grant procedures. The EPC establishes several organs to handle the various aspects of the patent application procedure. The European Patent Office (EPO), located in Munich, is the international equivalent of a national patent office. Its administrative divisions are the General Search Division, the Examining Division, and the Opposition Division. The Receiving Section is at The Hague. The first procedural step is the filing of an application at either a national patent office or directly with the EPO.4 The application may be in any of the three official languages (English, French, or German) and the applicant's choice becomes the language of the proceedings.5 The Receiving Section subjects the application to both a preliminary6 and a supplementary formal examination to determine whether it is in proper form and all fees are paid. -
PCT Applicant's Guide – National Phase
DE PCT Applicant’s Guide – National Phase – National Chapter – DE Page 1 GERMAN PATENT AND TRADE MARK OFFICE (DEUTSCHES PATENT- UND MARKENAMT) AS DESIGNATED (OR ELECTED) OFFICE CONTENTS THE ENTRY INTO THE NATIONAL PHASE—SUMMARY THE PROCEDURE IN THE NATIONAL PHASE ANNEXES Fees ............................................................... Annex DE.I National processing request form (patents) .................................. Annex DE.II National processing request form (utility models) .............................. Annex DE.III Declaration concerning the inventor ....................................... Annex DE.IV List of abbreviations: Office: German Patent and Trade Mark Office PatG: Patent Act [Patentgesetz] GebrMG: Utility Model Act [Gebrauchsmustergesetz] IntPatÜbkG: Act on International Patent Conventions [Gesetz über internationale Patentübereinkommen] PatKostG: Patent Costs Act [Patentkostengesetz] PatKostZV: Ordinance on Payment of Patent Costs of the German Patent and Trade Mark Office and the Federal Patent Court [Patentkostenzahlungsverordnung] DPMAV: Ordinance concerning the German Patent and Trade Mark Office [Verordnung über das Deutsche Patent- und Markenamt] (25 March 2021) DE PCT Applicant’s Guide – National Phase – National Chapter – DE Page 3 SUMMARY Designated SUMMARY (or elected) Office DE GERMAN PATENT AND DE TRADE MARK OFFICE Summary of requirements for entry into the national phase Time limits applicable for entry into the Under PCT Article 22(1): 30 months from the priority date national phase: Under PCT Article -
Guidelines for Examination in the European Patent Office
GUIDELINES FOR EXAMINATION IN THE EUROPEAN PATENT OFFICE Published by the European Patent Office Published by the European Patent Office Directorate Patent Law 5.2.1 D-80298 Munich Tel.: (+49-89) 2399-4512 Fax: (+49-89) 2399-4465 Printed by: European Patent Office, Munich Printed in Germany © European Patent Office ISBN 3-89605-074-5 a LIST OF CONTENTS page General Part Contents a 1. Preliminary remarks 1 2. Explanatory notes 1 2.1 Overview 1 2.2 Abbreviations 2 3. General remarks 3 4. Work at the EPO 3 5. Survey of the processing of applications and patents at the EPO 4 6. Contracting States to the EPC 5 7. Extension to states not party to the EPC 5 Part A – Guidelines for Formalities Examination Contents a Chapter I Introduction I-1 Chapter II Filing of applications and examination on filing II-1 Chapter III Examination of formal requirements III-1 – Annex List of Contracting States to the Paris Convention (see III, 6.2) III-20 Chapter IV Special provisions IV-1 Chapter V Communicating the formalities report; amendment of application; correction of errors V-1 Chapter VI Publication of application; request for examination and transmission of the dossier to Examining Division VI-1 Chapter VII Applications under the Patent Cooperation Treaty (PCT) before the EPO acting as a designated or elected Office VII-1 Chapter VIII Languages VIII-1 Chapter IX Common provisions IX-1 Chapter X Drawings X-1 Chapter XI Fees XI-1 Chapter XII Inspection of files; communication of information contained in files; consultation of the Register of European -
Prior Art Searches in Software Patents – Issues Faced
Journal of Intellectual Property Rights Vol 23, November 2018, pp 243-249 Prior Art searches in Software Patents – Issues Faced Shabib Ahmed Shaikh, Alok Khode and Nishad Deshpande,† CSIR Unit for Research and Development of Information Products, Tapovan, S.No. 113 & 114, NCL Estate, Pashan Road, Pune - 411 008, Maharashtra, India Received: 15 November 2017; accepted: 24 November 2018 Prior-art-search is a critical activity carried out by intellectual property professionals. It is usually performed based on known source of literature to ascertain novelty in a said invention. Prior-art-searches are also carried out for invalidating a patent, knowing state of the art, freedom to operate studies etc. In many technological domains such as chemistry, mechanical etc., prior art search is easy as compared to domain such as software. In software domain, prior-art can prove to be a complex and tedious process relying heavily on non-patent literature which acts as a pointer to the current technological trends rather than patent documents. This paper tries to highlight the issues faced by patent professionals while performing prior-art search in the field of software patents. Keywords: Patents, Software patents, World Intellectual Property Organisation, Prior art, Search Issues A patent is a form of intellectual property. It provides The identification of the relevant prior art, comprising exclusionary rights granted by national IP office to an of existing patents and scientific or non-patent inventor or their assignee for a limited period of time literature is important as it has bearing on the quality in exchange for public disclosure of an invention. -
Obviousness and the Doctrine of Equivalents in Patent Law: Striving for Objective Criteria
Catholic University Law Review Volume 43 Issue 2 Winter 1994 Article 7 1994 Obviousness and the Doctrine of Equivalents in Patent Law: Striving for Objective Criteria Stephen G. Kalinchak Follow this and additional works at: https://scholarship.law.edu/lawreview Recommended Citation Stephen G. Kalinchak, Obviousness and the Doctrine of Equivalents in Patent Law: Striving for Objective Criteria, 43 Cath. U. L. Rev. 577 (1994). Available at: https://scholarship.law.edu/lawreview/vol43/iss2/7 This Comments is brought to you for free and open access by CUA Law Scholarship Repository. It has been accepted for inclusion in Catholic University Law Review by an authorized editor of CUA Law Scholarship Repository. For more information, please contact [email protected]. OBVIOUSNESS AND THE DOCTRINE OF EQUIVALENTS IN PATENT LAW: STRIVING FOR OBJECTIVE CRITERIA The United States Constitution grants Congress the power to promote technological innovation by granting to inventors the exclusive right to their discoveries in the form of patents.' Congress has delegated the duty of granting patents to the Commissioner of the Patent and Trademark Office.2 The exclusionary right a patent provides' is effected through a civil action alleging infringement of the patent and seeking injunctive re- lief, damages, or both.' Patent law can be divided into two general procedural periods-the first relating to the procedure of procuring a patent from the Patent and Trademark Office, and the second relating to the enforcement of the in- ventor's right to exclude others from exploiting the patented invention.5 In the first period, the invention is fully described in an application con- taining a disclosure,6 followed by claims designed to outline precisely 1. -
Intellectual Property Guide
Intellectual Property Guide Attorney Advertising Material Table of Contents Types of Intellectual Property . 2 Patent Overview . 3 • Eligible Inventions . 4 • Types of Patents . 6 • Benefits of Patents . 7 • Implications for New Products . 7 How to Patent an Invention • Filing a Patent Application . 8 • Inventor’s Notebook and Communication Guidelines . 9 • Patent Do’s and Don’ts . 10 • Timelines . 11 • Background Research . 12 Trade Secret Overview . 13 Trademark Overview . 14 Copyright Overview . 16 Additional Resources . 17 Appendix • Flow Chart for 102(a)(1) and 102(b)(1) Analysis . 19 • Flow Chart for 102(a)(1) and 102(b)(1) Analysis . 20 In today’s world, a company’s intellectual property is often its most valuable asset . This is true not only for technology-based businesses, but also for manufacturers, life science companies, financial institutions, healthcare organizations and many other service providers both large and small . Intellectual property can provide a competitive advantage for its owner and can even create a separate revenue stream . Many innovations that consumers and businesses use and rely on every day became commercially viable due to solid intellectual property protection . Intellectual property rights offer innovators and developers a time-limited exclusivity to use and profit from the fruits of their inventive and creative efforts . This exclusivity encourages innovators to create, which ultimately inures to the benefit of society as a whole. This is your guide to intellectual property: the definitions, rationale and strategic considerations that will help advance the development of innovation into valuable assets for your organization . The information contained in this publication does not constitute legal advice. -
2200 Citation of Prior Art and Reexamination of Patents
Chapter 2200 Citation of Prior Art and Reexamination of Patents Citation of Prior Art and Reexamination of Patents 2247 Decision on Request for Reexamination, 2201 Introduction Request Denied 2202 Citation of Prior Art 2247.01 Examples of Decisions on Request for 2203 Persons Who May Cite Prior Art Reexamination 2204 Time for Filing Prior Art Citation 2248 Petition From Denial of Request 2205 Content of Prior Art Citation 2249 Patent Owner's Statement 2206 Handling of Prior Art Citation 2250 Amendment by Patent Owner 2207 Entry of Court Decision in Patent File 2250.01 Correction of Patent Drawings 2208 Service of Citation on Patent Owner 2251 Reply by Requester 2252 Consideration of Statement and Reply 2209 Reexamination 2253 Consideration by Examiner 2210 Request for Reexamination 2254 Conduct of Reexamination Proceedings 2211 Time for Requesting Examinations 2255 Who Reexamines 2212 Persons Who May File a Request 2256 Prior Art Patents and Printed Publications 2213 Representative of Requester Considered by Examiner in Reexamination 2214 Content of Request 2257 Listing of Prior Art 2215 Fee for Requesting Reexamination 2258 Scope of Reexamination 2216 Substantial New Question of Patentability 2259 Collateral Estoppel In Reexamination 2217 Statement in the Request Applying Prior Art Proceedings 2218 Copies of Prior Art 2260 Office Actions 2219 Copy of Printed Patent 2260.01 Dependent Claims 2220 Certificate of Service 2261 Special Status For Action 2221 Amendments Included in Request by 2262 Form and Content of Office Action Patent Owner -
Novelty and Inventive Step
1 NOVELTY AND INVENTIVE STEP Introduction If you wish to obtain a patent right in Japan, your claimed invention has to fulfill certain requirements as stipulated in the Japanese Patent Law. The major requirements include: - [Industrial Applicability] Claimed invention has to be industrially applicable (Japanese Patent Law, Article 29, Paragraph 1, Main Paragraph); - [Novelty] Claimed invention has not been publicly known in Japan or elsewhere (Japanese Patent Law Article 29, Paragraph 1 (and Article 29bis)); - [Inventive Step] Claimed invention could not have been easily conceived of (Japanese Patent Law, Article 29, Paragraph 2]; - [First-to-File System] Claimed invention has not been filed by third parties (Japanese Patent Law, Article 39 (and Article 29bis)) - [Description Requirements] Description of specification and recitation of claims have to satisfy certain description requirements (Japanese Patent Law, Article 36) In particular, reasons for rejection about novelty and inventive step are often listed in Office Actions, and they also become issues of contention at the court. NOVELTY The judgement regarding novelty is based on the timing of the filing of a patent application (international filing date for PCT- based applications, and priority date for Paris Convention-based applications). Please note that not only the date but also the exact time of filing a patent application is considered to be the subject for the judgement. Therefore, it is very important to conduct a thorough prior art search before filing a patent application. Inventions which lack novelty include: 1. Those publicly known in Japan or in overseas countries prior to filing (for example, TV broadcasting) 2. Those publicly worked in Japan or in overseas countries prior to filing (for example, in-store sales, factory tour) 3. -
How Valid Are U.S. Criticisms of the Japanese Patent System Michael Todd Helfand
Hastings Communications and Entertainment Law Journal Volume 15 | Number 1 Article 4 1-1-1992 How Valid Are U.S. Criticisms of the Japanese Patent System Michael Todd Helfand Follow this and additional works at: https://repository.uchastings.edu/ hastings_comm_ent_law_journal Part of the Communications Law Commons, Entertainment, Arts, and Sports Law Commons, and the Intellectual Property Law Commons Recommended Citation Michael Todd Helfand, How Valid Are U.S. Criticisms of the Japanese Patent System, 15 Hastings Comm. & Ent. L.J. 123 (1992). Available at: https://repository.uchastings.edu/hastings_comm_ent_law_journal/vol15/iss1/4 This Article is brought to you for free and open access by the Law Journals at UC Hastings Scholarship Repository. It has been accepted for inclusion in Hastings Communications and Entertainment Law Journal by an authorized editor of UC Hastings Scholarship Repository. For more information, please contact [email protected]. How Valid Are U.S. Criticisms of the Japanese Patent System? by MICHAEL TODD HELFAND* Table of Contents I. An Overview of the Japanese Patent System ............... 125 A. Japanese Patent Office Patent Practice ................. 126 B. A Comparison of Relevant Statistics ................... 132 II. Japanese Conceptions of the Japanese Patent System ....... 133 III. An Introduction to U.S. Criticisms and Their Analysis .... 138 IV. Getting Behind U.S. Criticisms of Japanese Procedure ..... 139 A. Costs of Using the System-An Issue of Language ..... 139 B. JPO Overload and Time Delays ....................... 142 1. Comprehensive Measures to Improve Overload and D elays ............................................ 143 a. Increase the number of patent examiners in the JPO ................................ 143 b. Employment of experts to assist examiners ...... 144 c. -
Drug Pricing and Pharmaceutical Patenting Practices
Drug Pricing and Pharmaceutical Patenting Practices February 11, 2020 Congressional Research Service https://crsreports.congress.gov R46221 SUMMARY R46221 Drug Pricing and Pharmaceutical Patenting February 11, 2020 Practices Kevin T. Richards, Intellectual property (IP) rights in pharmaceuticals are typically justified as necessary to allow Coordinator manufacturers to recoup their substantial investments in research, development, and regulatory Legislative Attorney approval. IP law provides exclusive rights in a particular invention or product for a certain time period, potentially enabling the rights holder (e.g., a brand-name drug manufacturer) to charge Kevin J. Hickey higher-than-competitive prices. If rights holders are able to charge such prices, they have an Legislative Attorney incentive to lengthen the period of exclusive rights as much as possible. Indeed, some commentators allege that pharmaceutical manufacturers have engaged in patenting practices that unduly extend the period of exclusivity. These critics argue that these patenting practices are used Erin H. Ward to keep drug prices high, without any benefit for consumers or innovation. Criticisms center on Legislative Attorney four such practices: “Evergreening”: So-called patent “evergreening” is the practice of filing for new patents on secondary features of a particular product as earlier patents expire, thereby extending patent exclusivity past the original twenty-year term. Later-filed patents may delay or prevent entry by competitors, thereby allowing the brand-name